ONNVF (ONNVF)
0.46
0.00 (0.00%)
Latest Headlines
Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
July 10, 2026 6:01 PM - StreetInsider
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
June 30, 2026 6:00 PM - StreetInsider
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
June 26, 2026 6:00 PM - StreetInsider
NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
June 26, 2026 8:30 AM - Globe NewsWire
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
June 23, 2026 6:00 PM - StreetInsider
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
June 19, 2026 6:01 PM - StreetInsider
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
June 16, 2026 6:01 PM - StreetInsider
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
June 9, 2026 6:00 PM - StreetInsider
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
June 5, 2026 6:00 PM - StreetInsider
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
June 2, 2026 6:00 PM - StreetInsider
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
May 19, 2026 6:00 PM - StreetInsider
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
May 15, 2026 6:00 PM - StreetInsider
Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
May 12, 2026 6:00 PM - StreetInsider
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
May 8, 2026 6:00 PM - StreetInsider
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
May 5, 2026 6:00 PM - StreetInsider
Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
May 1, 2026 6:00 PM - StreetInsider
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
April 28, 2026 6:00 PM - StreetInsider
Full Article List
